Copyright
©The Author(s) 2017.
World J Clin Cases. Mar 16, 2017; 5(3): 73-81
Published online Mar 16, 2017. doi: 10.12998/wjcc.v5.i3.73
Published online Mar 16, 2017. doi: 10.12998/wjcc.v5.i3.73
Beginning at the lowest possible dose and titrating upwards base on tolerability and efficacy |
Longer dosing interval and regular monitoring are recommended |
Switching to another opioid might be indicated in cases of unacceptable side effects of insufficient analgesia |
The oral route may be the most convenient |
Low-doses of strong opioids should be preferred to weak opioids because of its effectiveness and safety |
Strong opioids generally recommended in frail old population are buprenorphine, hydromorphone and oxycodone (including oxycodone/naloxone formulation) |
Controlled-release formulation and transdermal formulations are generally preferred (low risk of addiction and adverse effects) |
Considering laxatives or oxycodone/naloxone to prevent constipation |
Over-the-counter analgesics use should be avoided |
- Citation: Guerriero F. Guidance on opioids prescribing for the management of persistent non-cancer pain in older adults. World J Clin Cases 2017; 5(3): 73-81
- URL: https://www.wjgnet.com/2307-8960/full/v5/i3/73.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v5.i3.73